Gastrointestinal effects of eating Quinoa (Chenopodium quinoa Willd.) in celiac patients

American Journal of Gastroenterology

Volumn 109, Issue 2, 2014, Pages 270-278

  Zevallos, Victor F ^a   Herencia, L Irene ^b   Chang, Fuju ^c   Donnelly, Suzanne ^a   Ellis, H Julia ^a   Ciclitira, Paul J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; CHENOPODIUM QUINOA; COHORT STUDIES; COMBINED MODALITY THERAPY; DIET, GLUTEN-FREE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PATIENTS; PHYTOTHERAPY; PLANT PREPARATIONS; PROSPECTIVE STUDIES; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893780216     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.431     Document Type: Article

References (29)

1. Junker Y, Zeissig S, Kim SJ et al. Wheat amylase trypsin inhibitors drive intestinal infl ammation via activation of toll-like receptor 4. J Exp Med 2012; 209: 2395-408.
2. Bai JC, Fried M, Corazza GR et al. World gastroenterology organisation global guidelines on celiac disease. J Clin Gastroenterol 2013; 47: 121-6.
3. Packaged Facts. Gluten-Free Foods and Beverages in the U.S., 4th edn. Packaged Facts: LA, 2012.
4. Kasarda DD. Grains in relation to celiac disease. Cereal Foods World 2001; 46: 209-10.
5. Janatuinen EK, Pikkarainen PH, Kemppainen TA et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033-7.
6. Kemppainen TA, Heikkinen MT, Ristikankare MK et al. Unkilned and large amounts of oats in the celiac disease diet: a randomized, controlled study. Scand J Gastroenterol 2008; 43: 1094-101.
7. Lundin KEA, Nilsen EM, Scott HG et al. Oats induced villous atrophy in celiac disease. Gut 2003; 52: 1649-52.
8. Cooper SEJ, Kennedy NP, Mohamed BM et al. Immunological indicators of celiac disease activity are not altered by long term oats challenge. Clin Exp Immunol 2013; 171: 313-8.
9. Verena AI, Sergey S, Andersen MN et al. Varietal Differences of quinoa's tolerance to saline conditions. Plant Soil 2012; 357: 117-29.
10. Bergamo P, Maurano F, Mazzarella G et al. Immunological evaluation of the alcohol-soluble protein fraction from gluten-free grains in relation to celiac disease. Mol Nutr Food Res 2011; 55: 1266-70.
11. Zevallos VF, Ellis HJ, Suligoj T et al. Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease. Am J Clin Nutr 2012; 96: 337-44.
12. Astier C, Moneret-Vautrin DA, Puillandre E et al. First case report of anaphylaxis to quinoa, a novel food in France. Allergy 2009; 64: 819-20.
13. Hong J, Convers K, Reeves N et al. Anaphylaxis to quinoa. Ann Allergy Asthma Immunol 2013; 110: 60-1.
14. Lee AR, Ng DL, Dave E et al. The effect of substituting alternative grains in the diet on the nutritional profi le of the gluten-free diet. J Hum Nutr Diet 2009; 22: 359-63.
15. Roy-Choudhury D, Cooke WT, Tan DT et al. Jejunal biopsy: criteria and signifi cance. Scand J Gastroenterol 1966; 1: 57-74.
16. Cooper A, O'Flynn N, Robson J et al. Risk assessment and lipid modifi cation for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ 2008; 336: 1246-8.
17. Ruuskanen A, Kaukinen K, Collin P et al. Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter? Scand J Gastroenterol 2010; 45: 1197-202.
18. Shidrawi RG, Przemioslo R, Davies DR et al. Pitfalls in diagnosing celiac disease. J Clin Pathol 1994; 47: 693-4.
19. Storsrud S, Olsson M, Arvidsson Lenner R et al. Adult celiac patients do tolerate large amounts of oats. Eur J Clin Nutr 2003; 57: 163-9.
20. West J, Logan RFA, Hill PG et al. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut 2003; 52: 960-5.
21. Lewis NR, Sanders DS, Logan RFA et al. Cholesterol profi le in people with newly diagnosed celiac disease: a comparison with the general population and changes following treatment. Br J Nutr 2009; 102: 509-13.
22. Brar P, Kwon YG, Hollen S et al. Change in lipid profi le in celiac disease: benefi cial effect of gluten-free diet. Am J Med 2006; 119: 786-90.
23. Baigent CF, Keech AF, Kearney PM et al. Effi cacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-78.
24. Ogier N, Amiot MJ, George S et al. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia. Eur J Nutr 2013; 52: 547-57.
25. Konishi Y, Arai N, Umeda J et al. Cholesterol lowering effect of the methanol insoluble materials from the quinoa seed pericarp. In: Katsuyoshi N (ed). Hydrocolloids Elsevier Science: Amsterdam, Holland, 2000, pp 417-22.
26. Foucault AS, Math é V, Lafont R et al. Quinoa extract enriched in 20-hydroxyecdysone protects mice from diet-induced obesity and modulates adipokines expression. Obesity 2012; 20: 270-7.
27. Wahab PJ, Meijer JWR, Mulder CJJ. Histologic follow-up of people with celiac disease on a gluten-free diet. Am J Clin Pathol 2002; 118: 459-63.
28. Lee SK, Lo W, Memeo L et al. Duodenal histology in patients with celiac disease aft er treatment with a gluten-free diet. Gastrointest Endosc 2003; 57: 187-91.
29. Nasseri-Moghaddam S, Modif A, Nouraie M et al. The normal range of duodenal intraepithelial lymphocytes. Arch Iran Med 2008; 11: 136-42.